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Children with Down syndrome (DS) are highly susceptible to acute leukaemia. Given the potential role of infections in the aetiology
of leukaemia in children without DS, we investigated whether there was an association between early-life infections and acute
leukaemia in children with DS. Maternal infections during pregnancy were also examined. We enrolled 158 incident cases of acute
leukaemia in children with DS (97 acute lymphoblastic leukaemia (ALL) and 61 acute myeloid leukaemia (AML)) diagnosed at
Children’s Oncology Group institutions between 1997 and 2002. DS controls (N¼173) were selected from the cases’ primary care
clinics and frequency matched on age at leukaemia diagnosis. Data were collected on demographics, child’s medical history, mother’s
medical history, and other factors by maternal interview. Analyses were conducted using unconditional logistic regression adjusted for
potential confounders. A significant negative association was observed between acute leukaemia and any infection in the first 2 years
of life (adjusted odds ratio (OR)¼0.55, 95% confidence interval (CI) (0.33–0.92); OR¼0.53, 95% CI (0.29–0.97); and OR¼0.59,
95% CI (0.28–1.25) for acute leukaemia combined, ALL, and AML respectively). The association between acute leukaemia and
maternal infections during pregnancy was in the same direction but not significant. This study offers support for the hypothesis that
early-life infections may play a protective role in the aetiology of acute leukaemia in children with DS.
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While the aetiology of childhood leukaemia remains largely
unknown (Ross et al, 1994; Pui, 1995), the association of childhood
acute leukaemia with Down syndrome (DS) has been recognised
for more than 70 years (Brewster and Cannon, 1930). Children
with DS, the most common chromosomal abnormality in the
United States (Centers for Disease Control & Prevention, 1994)
have an estimated 10- to 30-fold increased risk of developing acute
leukaemia compared to children without DS (Fong and Brodeur,
1987; Robison, 1992; Taub, 2001).
In addition to being the most common genetic disorder linked
to the development of leukaemia, trisomy 21 is one of the most
common acquired abnormalities in the leukaemic cells of patients
without DS (Sakurai and Swansbury, 1984). Several genes on
chromosome 21 may be disrupted in children with acute leukaemia
and specific gene translocations involving chromosome 21 have
been implicated in leukaemia development (Okuda et al, 1998).
These findings represent accumulating evidence that genes on
chromosome 21 may be causally linked to the development of
leukaemia. Despite this evidence, it is estimated that only 1% of
children with DS will ever develop the disease (Taub, 2001). Host
genetic susceptibility and environmental exposures likely work
together to give rise to leukaemia (Greaves, 1988). For children
with DS, trisomy 21 may confer increased genetic susceptibility
and represent the first step in a complex multistep pathway to
leukemogenesis (Scholl et al, 1982; Ross, 1999). Additional
environmental exposures, including those thought to be related
to leukaemia in children without DS, are probably also required.
Thus, investigations of environmental risk factors for leukaemia in
children with DS may help untangle complex gene–environment
interactions and provide clues not only to the aetiology of acute
leukaemia in children with DS but also for leukaemia in the general
population.
Greaves proposed that childhood acute lymphoblastic leukaemia
(ALL), a variant comprising the majority of childhood leukaemia,
develops as the result of at least two independent and sequential
genetic mutations (Greaves et al, 1985; Greaves, 1988). The first
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lmutation occurs during the expansion of B-cell precursors in
utero, giving rise to a population of preleukaemic clone cells
(Greaves, 1988; Greaves et al, 2003); the second mutation occurs in
a mutant clone during postnatal proliferation of B cells. Greaves
hypothesised that exposure to common infections in early
childhood may protect the child against ALL by contributing to
normal maturation of the immune system, whereas children whose
exposure is delayed will be at comparatively higher risk (Greaves,
1988, 1997; Greaves and Alexander, 1993). Some studies have
supported the possible role of delayed infection in the aetiology of
childhood leukaemia (van Steensel-Moll et al, 1986; McKinney et al,
1999; Schuz et al, 1999; Neglia et al, 2000). However, results have
been inconsistent, potentially due to the heterogeneity of child-
hood leukaemia and insufficient study power to test the hypothesis
within leukaemia subgroups (Ross, 1999; Jourdan-Da Silva et al,
2004).
We investigated whether there was an association between
infections and acute leukaemia among children with DS.
Specifically, we evaluated whether children with DS and leukaemia
experienced more infections in the first 2 years of life than did
children with DS who did not have leukaemia. In addition, we
examined whether case mothers experienced more urinary tract
infections (UTIs) and kidney infections during pregnancy than did
control mothers.
METHODS
Case identification
Children with DS diagnosed with incident acute leukaemia
between January 1997 and October 2002 were identified through
the registration files of the Children’s Oncology Group (COG).
COG formed from the merger of the Children’s Cancer Group and
the Paediatric Oncology Group and consists of 238 member
institutions in the United States, Canada, Australia, and Europe.
Together they care for an estimated 94% of leukaemia patients
under the age of 15 years and 73% of leukaemia patients under the
age of 20 years in the United States (Ross et al, 1996; Liu et al,
2003).
The eligibility criteria for cases were: a diagnosis of incident
acute leukaemia at age 19 years or earlier, residence in the United
States or Canada at the time of diagnosis, presence of a telephone
in the home (for comparability to a second group of control
children without DS who were selected through random digit
dialing), and the availability of an English-speaking biological
mother for interview. In addition, authorisation from the patient’s
COG physician to contact the child’s parents, and written consent
for interview from the mother were required. Institutional Review
Boards of the University of Minnesota and participating COG
institutions approved this study.
Control identification
Upon completion of the telephone interview, case mothers were
asked to provide the name and address of the physician
responsible for their child’s primary care before diagnosis of
leukaemia. These physicians were contacted and asked to provide
a roster of pediatric patients with DS in their practice who had no
history of leukaemia. Potential controls with DS were randomly
selected from the rosters and frequency matched to case subjects
on age at leukaemia diagnosis (0, 1–3, 4–6, 7–10, 11–14, and 15–
18 years). As with cases, eligible controls were required to have an
available telephone in their residence and an English speaking
biologic mother available for telephone interview. Permission from
the child’s primary care physician to contact the child’s parents
and written consent to interview from the mother were also
required.
Data collection
Mothers were interviewed using a structured, computer-assisted
telephone questionnaire. Data on demographics, mother’s medical
history, pregnancy and family characteristics, and personal habits
(i.e. smoking and alcohol consumption) were collected along with
the index child’s medical history. In addition, information
regarding maternal kidney infections and UTIs occurring during
the index pregnancy was collected, since medications used to treat
these conditions were of interest. The child’s medical history
included history of mumps, chicken pox, rubella, regular measles,
ear infections, colds, and bronchial infections. An open-ended
question probing for any other serious illness or disease in the
child was asked, and these conditions were coded according to the
9th edition of the International Classification of Diseases. The
child’s age at the first diagnosis of a reported infection was
ascertained in years. If the child first experienced the infection
before 2 years of age, then age in months at the time of infection
was also collected.
Each child was assigned a reference date prior to the interview to
make the data collection process similar for cases and DS controls.
Cases were assigned a reference date corresponding to a date 6
months prior to leukaemia diagnosis. For controls, the reference
date was a randomly selected day in the 12 months surrounding
the control child’s birthday in the year assigned by the frequency
match. On average, interviews occurred 21 months after leukaemia
diagnosis (o12 months for 59 cases, 12–24 months for 33 cases,
and 424 months for 66 cases). Interviews with control mothers
occurred an average of 2 months after their child’s eligibility was
determined.
Detailed clinical information on all DS cases was available from
COG institutions. Leukaemia morphology was assigned at the COG
institutions, and centrally reviewed and classified by COG
investigators. Cytogenetic data were collected from the primary
physician of DS controls and were centrally reviewed and verified
by COG investigators.
Statistical analyses
Odds ratios (OR) and 95% confidence intervals (CI) were used to
measure the effect of maternal and child infections on leukaemia
risk and were estimated using unconditional logistic regression
models (SAS
r Version 8.02. analytical software; SAS Institute Inc.,
Cary, NC, USA). Analyses included all acute leukaemia combined,
as well as stratified by acute leukaemia subgroups (ALL and acute
myeloid leukaemia (AML)). Maternal infections during pregnancy
included each type of infection, as well as infections combined into
a single category and compared to those without a history of
infection during pregnancy. Analyses of the association between
acute leukemia and child infections were restricted to children
over 1 year of age at diagnosis, or the corresponding reference date
for controls, to ensure that there was an adequate window for
exposure to infections. In addition, evidence indicates that
leukaemia in the first year of life probably develops in utero,
and thus postnatal exposures may not play an aetiologic role
(Greaves et al, 2003). Six (4%) cases (one ALL and five AML) and
21 (12%) controls were younger than 1 year of age.
Children were classified as exposed if the infections occurred in
the first 2 years of life and more than 1 year prior to diagnosis of
leukaemia (or corresponding date for controls). The latter
restriction served to minimise the possibility that infection was
due to preleukaemic symptoms or conditions. Postnatal chicken
pox, ear infections, and colds and bronchial infections were
analysed separately along with a category for any other reported
infections. The occurrences of chicken pox, ear infections, measles,
colds, and bronchial infections were combined into a summary
category and compared to those participants without a history of
childhood infection. As the category for other infections was
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lheterogeneous, it was not included in results reported for the
summary measure of any infection but was analysed as a separate
category. The effect of the number of reported infections (0, 1, 2–
3) was also evaluated.
Tests for linear trend were evaluated by treating categorical
variables as ordinal. Regression models were adjusted for age using
a categorical variable (o2, 2–6, 46 years) to distinguish between
cases occurring during the peak incidence of ALL and other
childhood leukaemia cases. Due to the absence of AML cases over
the age of 6, age was adjusted into two categories (o2 and X2
years) for that group. Multivariate-adjusted analyses were
performed to evaluate the potential confounding effects of various
socio-demographic characteristics and presumed risk factors.
Potential confounders identified a priori included the child’s sex,
race, birth weight, gestational age, birth order, number of older
siblings, breast feeding, household income, maternal education,
smoking during pregnancy, and drinking during pregnancy.
Child’s race was considered to be white if both parents reported
being white, and non-white if either or both parents reported
another race or ethnicity. A potential confounder was retained in
the final multivariate model if it changed the age-adjusted
parameter estimate for combined leukaemia in a meaningful way
(e.g. 410%). In addition, household income was retained
concurrent with maternal education to arrive at the best estimate
of socioeconomic status.
RESULTS
During the study period, a total of 210 potential cases were
identified through 116 COG institutions participating in the study.
Interviews were successfully completed for 158 (75%) of those
eligible. Reasons for noninterview included maternal refusal
(17%), physician refusal (5%), and inability to locate mother
(3%). Of the successfully completed telephone interviews, 97 cases
were diagnosed with ALL and 61 with AML.
Of 151 clinics contacted to provide information regarding DS
controls, 47 refused or were unable to provide rosters of potential
DS controls and 27 had no other age eligible children with DS to
refer. In total, 77 clinics provided rosters enumerating 726
potential controls; 329 potential controls were selected by study
investigators based on date of birth. Of these potential controls, a
name and address was not provided to the University of Minnesota
for the following reasons: the families could not be located or were
no longer seen by the clinic (N¼46), the families refused the
clinic’s request (N¼19), the clinic determined the child was not
eligible (N¼18), the clinic chose not to contact them (N¼8), or
for reasons the clinics did not report (N¼23). Names and
addresses from a total of 215 mothers were forwarded to study
investigators. Nine (4%) potential controls were found ineligible
by the University of Minnesota. The remaining mothers of
potential control children with DS were not interviewed due to
refusal (11%) or inability to schedule an interview (4%). Telephone
interviews were successfully completed for 173 mothers (80.5%) of
the 215 potential DS controls.
Selected characteristics of the 158 cases and 173 controls are
shown in Table 1. While the overall mean age was similar for cases
and controls (5.00 and 4.64 years, respectively), cases comprised a
higher percentage of the 2–6 year age group at diagnosis
(P¼0.05). Cases and controls were very similar with regard to
breast feeding, birth order, number of older siblings, child’s sex,
birth weight, and gestational age. Study participants were
predominantly white; however, cases were more likely to be non-
white than controls. Mothers’ mean age at the index child’s birth
did not differ significantly between cases and controls (32.5 years
for cases and 31.9 years for controls; P¼0.50), although case
mothers were more likely to have been over the age of 35 when the
index child was born (P¼0.08). Mothers of cases, in particular
mothers of ALL case patients, had an overall lower educational
level than mothers of controls. However, cases and controls were
very similar with respect to household income and mother’s
marital status. There was a tendency of mothers of control subjects
Table 1 Characteristics of 158 Down syndrome leukaemia cases and 173 Down syndrome controls
a
Controls
Childhood leukaemia cases Acute lymphoblastic leukaemia cases Acute myeloid leukaemia cases
Characteristic or exposure N¼173 (%) N¼158 (%) P-value N¼97 (%) P-value N¼61 (%) P-value
Gender
Male 90 (52.0) 85 (53.8) 0.75 57 (58.8) 0.29 28 (45.9) 0.41
Female 83 (48.0) 73 (46.2) 40 (41.2) 33 (54.1)
Child’s race
White 145 (83.8) 121 (76.6) 0.10 77 (79.4) 0.36 44 (72.1) 0.05
Non-white 28 (16.2) 37 (23.4) 20 (20.6) 17 (27.9)
Age at reference date (years)
o2 77 (44.5) 63 (39.9) 0.05 13 (13.4) o0.0001 50 (82.0) o0.0001
2–6 51 (29.5) 66 (41.8) 55 (56.7) 11 (18.0)
46 45 (26.0) 29 (18.4) 29 (29.9) 0 (0.0)
Birthweight (g)
p3500 136 (78.6) 124 (79.5) 0.85 80 (82.5) 0.45 44 (74.6) 0.52
43500 37 (21.4) 32 (20.5) 17 (17.5) 15 (25.4)
Weeks gestation at birth
p38 85 (49.4) 69 (43.7) 0.30 45 (46.4) 0.63 24 (39.3) 0.18
438 87 (50.6) 89 (56.3) 52 (53.6) 37 (60.7)
Infections and leukaemia in children with Down syndrome
KN Canfield et al
1868
British Journal of Cancer (2004) 91(11), 1866–1872 & 2004 Cancer Research UK
C
l
i
n
i
c
a
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particularly mothers of AML cases (P¼0.006).
An episode of shingles during pregnancy was reported for only
one case mother and one control mother. No cases of rubella,
regular measles, mumps, or mononucleosis during pregnancy were
reported for any case or control mothers. Associations between
childhood acute leukaemia and maternal UTIs during pregnancy
with the index child suggested a decreased risk, although the ORs
were imprecise (data not shown). The ORs for having had any UTI
during pregnancy were 0.73 (95% CI: 0.38–1.42) for total
leukaemia, 0.67 (95% CI: 0.28–1.59) for ALL, and 0.88 (95% CI:
0.35–2.19) for AML. No correlation was observed between report
of maternal infections and report of child infections (r¼0.01,
P¼0.83).
The results of analyses examining the association between acute
leukaemia and early childhood infections are shown in Table 2.
Mothers of 69 cases (52 ALL and 17 AML) and 87 controls reported
at least one common infection in the first 2 years of their child’s
life. Ear infections, colds, and bronchial infections were pre-
dominant, while chicken pox and other infections were reported
less frequently. A history of measles in the first 2 years of life was
reported for only two control and no case subjects. A statistically
Maternal age at child’s birth
p35 121 (69.9) 96 (60.8) 0.08 63 (65.0) 0.40 33 (54.1) 0.02
435 52 (30.1) 62 (39.2) 34 (35.0) 28 (45.9)
Breast feeding
Breastfed 34 (19.7) 25 (15.8) 0.66 12 (12.4) 0.31 13 (21.3) 0.94
Bottlefed 46 (26.6) 44 (27.9) 29 (29.9) 15 (24.6)
Both 93 (53.8) 89 (56.3) 56 (57.7) 33 (54.1)
Child’s birth order
Firstborn 56 (32.4) 47 (29.8) 0.61 30 (30.9) 0.81 17 (27.9) 0.51
Not firstborn 117 (67.6) 111 (70.3) 67 (69.1) 44 (72.1)
Number of older siblings
0 56 (32.4) 47 (29.8) 0.62 30 (30.9) 0.46 17 (27.9) 0.46
1 57 (32.9) 56 (35.4) 29 (29.9) 27 (44.3)
2 26 (15.0) 30 (19.0) 22 (22.7) 8 (13.1)
3 or more 34 (19.7) 25 (15.8) 16 (16.5) 9 (14.8)
Mother’s marital status
Married or living as married 152 (89.4) 140 (88.6) 0.74 89 (91.8) 0.71 51 (83.6) 0.13
Divorced, separated, widowed 14 (8.2) 12 (7.6) 7 (7.2) 5 (8.2)
Never married 4 (2.4) 6 (3.8) 1 (1.0) 5 (8.2)
Income at child’s birth
o$30000 57 (33.1) 57 (36.5) 0.79 37 (38.5) 0.60 20 (33.3) 0.97
$30000–$75000 84 (48.9) 71 (45.5) 41 (42.7) 30 (50.0)
4$75000 31 (18.0) 28 (18.0) 18 (18.8) 10 (16.7)
Mother’s educational level
oHigh school graduate 9 (5.2) 17 (10.8) 0.05 16 (16.5) 0.005 1 (1.6) 0.18
High school graduate 89 (51.8) 90 (57.0) 51 (52.6) 39 (63.9)
4High school graduate 74 (43.0) 51 (32.2) 30 (30.9) 21 (34.5)
Maternal smoking during pregnancy
Yes 27 (15.6) 30 (19.0) 0.42 19 (19.6) 0.40 11 (18.0) 0.66
No 146 (84.4) 128 (81.0) 78 (80.4) 50 (82.0)
Maternal drinking during pregnancy
Yes 71 (41.0) 49 (31.0) 0.06 36 (37.1) 0.53 13 (21.3) 0.006
No 102 (59.0) 109 (69.0) 61 (62.9) 48 (78.7)
aNumbers in tables may not sum to total number of cases/controls due to missing values.
Table 1 (Continued)
Controls
Childhood leukaemia cases Acute lymphoblastic leukaemia cases Acute myeloid leukaemia cases
Characteristic or exposure N¼173 (%) N¼158 (%) P-value N¼97 (%) P-value N¼61 (%) P-value
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lsignificant negative association was observed between acute
leukaemia and combined report of ear infections, chicken pox,
measles, colds, and bronchial infections in the first 2 years of life
for combined acute leukaemia (OR¼0.55; 95% CI¼0.33–0.92)
and ALL (OR¼0.53; 95% CI¼0.29–0.97). An inverse association
with AML was observed that was of a similar strength but not
significant (OR¼0.59; 95% CI¼0.28–1.25). There was evidence of
a significant linear trend with increasing numbers of infection (P
for trend¼0.03); however, a dose–response relationship was not
apparent in the analysis of number of infections as a categorical
variable. Associations between childhood acute leukaemia and
infections examined individually were consistently negative,
although none reached statistical significance. A strong, significant
negative association was observed between other reported infec-
tions and combined acute leukaemia (OR¼0.23; 95% CI¼0.07–
0.73) and ALL (OR¼0.15; 95% CI¼0.03–0.75).
Finally, analysis for combined acute leukaemia and infection
was restricted to cases (N¼67) for whom a control from the same
clinic was enrolled. Although more imprecise, there were no
notable differences in the results (data not shown).
DISCUSSION
This is the largest case–control study of leukaemia in children
with DS yet conducted (Garre et al, 1987; Mejia-Arangure et al,
2003) and the first to evaluate whether the timing of common
infections is associated with a reduced risk of acute leukaemia in
children with DS. Infections in the first 2 years of life were
associated with a reduced risk of acute leukaemia among children
with DS. The strength of the association was similar across
subtypes. In addition, the association between acute leukaemia and
maternal infections during pregnancy, although weaker, were in
the same direction as those observed for infections of the child.
Thus, taken together our study offers support for the hypothesis
that early exposure to common infections may be important in the
aetiology of leukaemia among children with DS. Only a small
proportion of children with DS will ever develop acute leukaemia,
which suggests that despite increased genetic susceptibility other
factors likely contribute to aetiology.
No investigation of the relationship between early infections and
leukaemia in children with DS comparable to ours exists. However,
a number of investigations have addressed the role of early
common infections in the aetiology of leukaemia in children
without DS, particularly ALL. While a few studies have observed
either positive or null associations between acute leukaemia and
early common infections,(Dockerty et al, 1999; Schuz et al, 1999;
Naumburg et al, 2002), most investigations have reported negative
associations(van Steensel-Moll et al, 1986; McKinney et al, 1999;
Schuz et al, 1999; Neglia et al, 2000; Perrillat et al, 2002; Jourdan-
Da Silva et al, 2004) Van Steensel-Moll et al observed a significant
negative association between ALL and common colds in the first
year of life (van Steensel-Moll et al, 1986). Neglia et al observed a
significant trend towards reduction in the risk of ALL with
increasing frequency of ear infections in the first year of life and
Perrillat et al reported a negative association between risk of ALL
and a history of four or more ear infections in the first two years of
life (Neglia et al, 2000; Perrillat et al, 2002). McKinney et al found a
significantly reduced risk of ALL with neonatal infections,
specifically skin infections, and recently Jourdan-Da Silva et al
observed a slight negative association with early infections,
particularly GI infections (McKinney et al, 1999; Jourdan-Da Silva
et al, 2004).
The biological explanation for a decreased risk of acute
leukaemia for children with DS who experience early common
infections may be very similar to that proposed for children
Table 2 Risk of acute leukaemia associated with early infections (restricted to children older than 1 year at diagnosis of leukaemia
a)
b
Childhood leukaemia Acute lymphoblastic leukaemia Acute myeloid leukaemia
Infections in first 2 years of life No. of controls No. of cases OR (95% CI)
c No. of cases OR (95% CI)
c No. of cases OR (95% CI)
c,d
Any infection
e
No 64 81 1.00 (reference) 43 1.00 (reference) 38 1.00 (reference)
Yes 87 69 0.55 (0.33–0.92) 52 0.52 (0.28–0.96) 17 0.59 (0.28–1.25)
Frequency of infection
e
0 64 81 1.00 (reference) 43 1.00 (reference) 38 1.00 (reference)
1 43 36 0.56 (0.31–1.00) 23 0.43 (0.21–0.91) 13 0.75 (0.33–1.69)
2–3 44 33 0.55 (0.30–1.02) 29 0.61 (0.30–1.22) 4 0.34 (0.10–1.13)
P-Trend¼0.03 P-Trend¼0.15 P-Trend¼0.07
Chicken pox
No 139 142 1.00 (reference) 88 1.00 (reference) 54 1.00 (reference)
Yes 12 7 0.51 (0.19–1.37) 6 0.62 (0.21–1.81) 1 0.24 (0.03–2.16)
Colds or bronchial infections
No 94 106 1.00 (reference) 60 1.00 (reference) 46 1.00 (reference)
Yes 57 44 0.66 (0.39–1.10) 35 0.74 (0.41–1.31) 9 0.59 (0.24–1.40)
Ear infections
No 87 95 1.00 (reference) 53 1.00 (reference) 42 1.00 (reference)
Yes 64 53 0.73 (0.44–1.22) 42 0.77 (0.43–1.39) 11 0.62 (0.27–1.43)
Other
No 136 145 1.00 (reference) 92 1.00 (reference) 53 1.00 (reference)
Yes 15 4 0.23 (0.07–0.73) 2 0.15 (0.03–0.75) 2 0.38 (0.08–1.90)
aCorresponding date for controls.
bNumbers in tables may not sum to total number of cases/controls due to missing values.
cORs adjusted for age at reference date, maternal
education level, and household income.
dAML adjusted for age at reference date in two categories (o2, X2) due to the absence of AML cases over 6 years of age at diagnosis.
eAny infection, and frequency of infection categories include chicken pox, ear infections, measles, colds, and bronchial infections.
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the increased susceptibility to leukaemia of children with DS may
be a consequence of impaired cellular immunity and found
evidence of an excessive humoral immune response (Sutnick et al,
1971). Children with DS are highly susceptible to infection and the
tendency towards an impaired immune system has been well
documented. Observed defects in immune function include
decreased white cell counts, impaired cell-to-cell communication,
reduced antibody levels, and abnormal lymphocyte function (Fong
and Brodeur, 1987; Novo et al, 1993). In the presence of
proliferative leukocyte stress provoked by infection, inherently
abnormal leukocyte stem cells in patients with DS may be at
increased risk of a second mutation resulting in leukaemia
(Stewart, 1961). Nevertheless, the types and frequency of infections
can vary across children with DS (Selikowitz, 1992).
Greaves’ hypothesis adds the importance of timing of the
infection. Delayed exposure to common infections increases the
pool of preleukaemic cells, while early exposure to common
infections may protect children from ALL by contributing to a
more normal maturation of the immune system (Greaves, 1988,
1997; Greaves and Alexander, 1993). The age-specific incidence
peak between 2 and 6 years of age characteristic to ALL in the
general population has been described for children with DS as well,
providing epidemiological support for an environmental contri-
butor to the aetiology of leukaemia in children with DS and
supporting Greaves’ hypothesis (Robison et al, 1984; Fong and
Brodeur, 1987; Greaves, 1997). Our results, however, indicate a
fairly nonspecific negative association, suggesting a possible
protective effect of early infections for both ALL and AML.
Genetically impaired immune systems are typically associated with
lymphoblastic malignancy, although patients with DS are at
increased risk of AML and ALL (Fong and Brodeur, 1987).
Jourdan-Da Silva also observed a negative association with early
infections that was not specific to ALL for children without DS
(Jourdan-Da Silva et al, 2004).
It is also important to consider the changing attitudes in recent
decades toward children with DS. Prior to the 1970s, children with
DS were often institutionalised and deprived of all but the most
basic of medical care (Van Riper and Cohen, 2001). In more recent
years, children with DS have been mainstreamed at an early age
with other children (often attending day care, preschool, as well
being integrated into regular classrooms) (Cuckle, 1999; Van Riper
and Cohen, 2001). Standards of medical care specific to DS have
also been recommended (Saenz, 1999; Van Riper and Cohen,
2001). Thus, the opportunity for and recognition of early-life
infections has likely increased. Unfortunately, we did not collect
data on day care experience, which has been shown in some
studies to be a surrogate marker for exposure to infections (Ma
et al, 2002; Perrillat et al, 2002).
A relatively small sample size is a limitation of this study,
resulting in some imprecise effect estimates. Response rates for
study participants were similar between cases and controls. It was
not possible to enroll DS controls for all primary care clinics that
referred DS leukaemia cases to COG institutions, introducing
potential bias if enrolled cases differ from leukaemia patients in
the population of children with DS in North America. However,
COG affiliated institutions treat over 90% of pediatric leukaemia
patients in the United States (Ross et al, 1996; Liu et al, 2003).
Therefore, it is likely that a child with DS diagnosed with
leukaemia at any clinic in the United States would be referred to,
and treated at a COG institution. In addition, restriction of analysis
to cases with an available clinic DS control did not significantly
alter our findings for combined acute leukaemia and child
infections. Further, children with DS maintain a more involved
clinical care regimen during childhood than children without DS,
with recommended pediatrician visits for scheduled exams every 6
months to a 1 year regardless of their health (Cohen, 1999; Van
Riper and Cohen, 2001). Therefore, it is unlikely that participating
primary care physicians were selectively referring children with DS
who were more often seen in their clinics with increased infections
as potential controls.
History of infections was ascertained by maternal report, and
was limited in this analysis to a set of a priori identified common
infections. The data were collected from a structured, computer-
assisted telephone questionnaire and the same standardised
interview was used to collect data from mothers of cases and
controls. An effort was made to collect data soon after case or
control identification and use of a reference date ensured that
mothers of cases and controls were recalling events over
approximately the same period of time. Mothers of children with
DS and leukaemia may have been motivated to actively think about
their child’s history, as well as their own past habits and
environmental exposures. The unique use of DS controls is a
strength of this study as mothers of control subjects might be
similarly motivated. It is likely that any under- or over-reporting of
exposure was more similar for mothers of cases and controls than
would be the case in a study of children without DS. Further, it is
unlikely that mothers were selectively under- or over-reporting a
history of infection for themselves, but not their child, or vice
versa, as we found no correlation between mothers reporting a
history of infections for themselves and their children.
In conclusion, this study offers support for the hypothesis that
early-life infections may play a protective role in the aetiology of
childhood acute leukaemia in children with DS. In future
investigations, molecular and biological methods may be useful
in characterizing the history of infection, providing a more
accurate measure of immune status, and further clarifying the
relationship between an impaired immune system and leukaemia
in children with DS.
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